Telix Pharmaceuticals | TLX - Equity Capital And Reserves

Stock Price
9.85
Daily Change
-0.28 -2.76%
Monthly
-10.54%
Yearly
-65.99%
Q1 Forecast
10.34

Telix Pharmaceuticals reported AUD568.21M in Equity Capital and Reserves for its fiscal semester ending in December of 2024.





Equity Capital And Reserves Change Date
Cochlear AUD 1.95B 82.7M Jun/2025
CSL USD 21.41B 861M Jun/2025
Integral Diagnostics AUD 301.71M 1.33M Jun/2024
Mayne Pharma AUD 454.19M 93.58M Jun/2024
Medical Developments International AUD 55.1M 229K Jun/2025
Mesoblast USD 597.44M 136.18M Jun/2025
Neuren Pharmaceuticals AUD 323.27M 40.63M Jun/2025
Pacific Edge NZD 26.9M 811K Dec/2025
Paradigm Biopharmaceuticals AUD 21.18M 12.88M Jun/2025
Polynovo AUD 72.12M 3.07M Jun/2024
PYC Therapeutics AUD 170.01M 114.57M Jun/2025
Ramsay Health Care AUD 5.71B 894M Jun/2025
ResMed USD 6.32B 199.62M Dec/2025
Sonic Healthcare AUD 8.2B 120.9M Dec/2024